Sign In
Buy RAPP
Rapport Therapeutics . Common Stock Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -72.29. In total, the insiders bought 1.38M and sold 1.25M RAPP shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-72.29 |
| ● Buy | 1.38M shares |
| ● Sell | 1.25M shares |
|
31% Buy Activity
Strong Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 26, 2026 Sell |
Third Rock Ventures V, L.p. 10 Percent Owner |
18 572 Value: $743.8K |
||
|
May 11, 2026 Sell |
Third Rock Ventures V, L.p. 10 Percent Owner |
133 618 Value: $5.38M |
||
|
May 08, 2026 Sell |
Third Rock Ventures V, L.p. 10 Percent Owner |
5 018 Value: $202.3K |
||
|
May 07, 2026 Sell |
Third Rock Ventures V, L.p. 10 Percent Owner |
271 495 Value: $10.9M |
||
|
Apr 17, 2026 Sell |
Third Rock Ventures V, L.p. 10 Percent Owner |
426 005 Value: $17.2M |
||
|
Apr 17, 2026 Sell |
Yeleswaram Krishnaswamy Chief Development Officer |
20 225 Value: $808.8K |
||
|
Apr 14, 2026 Sell |
Yeleswaram Krishnaswamy Chief Development Officer |
10 200 Value: $357.8K |
||
|
Apr 13, 2026 Sell |
Yeleswaram Krishnaswamy Chief Development Officer |
9 165 Value: $320.5K |
||
|
Apr 10, 2026 Sell |
Yeleswaram Krishnaswamy Chief Development Officer |
500 Value: $17.5K |
||
|
Apr 08, 2026 Sell |
Yeleswaram Krishnaswamy Chief Development Officer |
360 Value: $12.6K |
||
|
Mar 30, 2026 Sell |
Gault Cheryl Chief Operating Officer |
7 161 Value: $200.8K |
||
|
Mar 30, 2026 Sell |
Gault Cheryl Chief Operating Officer |
2 839 Value: $81.1K |
||
|
Mar 25, 2026 Sell |
Yeleswaram Krishnaswamy Chief Development Officer |
10 115 Value: $303.4K |
||
|
Mar 05, 2026 Sell |
Gault Cheryl Chief Operating Officer |
2 014 Value: $58.3K |
||
|
Feb 19, 2026 Buy |
Bredt David Chief Scientific Officer |
6 000 Value: $10.8K |
||
|
Feb 19, 2026 Buy |
Bredt David Chief Scientific Officer |
6 000 Value: $10.8K |
||
|
Feb 18, 2026 Sell |
Ceesay Abraham Chief Executive Officer |
3 552 Value: $103.2K |
||
|
Feb 18, 2026 Sell |
Ceesay Abraham Chief Executive Officer |
2 281 Value: $68.0K |
||
|
Feb 18, 2026 Sell |
Ceesay Abraham Chief Executive Officer |
2 983 Value: $86.6K |
||
|
Feb 18, 2026 Sell |
Ceesay Abraham Chief Executive Officer |
2 100 Value: $62.6K |
||
|
Feb 17, 2026 Sell |
Bredt David Chief Scientific Officer |
900 Value: $25.2K |
||
|
Feb 17, 2026 Sell |
Bredt David Chief Scientific Officer |
5 400 Value: $156.3K |
||
|
Feb 17, 2026 Sell |
Bredt David Chief Scientific Officer |
2 200 Value: $65.1K |
||
|
Feb 02, 2026 Buy |
Sevigny Jeffrey Chief Medical Officer |
130 000 Value: $3.61M |
||
|
Feb 02, 2026 Buy |
Ceesay Abraham Chief Executive Officer |
428 000 Value: $11.9M |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
